# Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

> **NCT02661438** · NA · COMPLETED · sponsor: **Bayer** · enrollment: 46 (actual)

## Conditions studied

- Bronchiectasis
- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Placebo to Ciprofloxacin DPI (BAYQ3939)

## Key facts

- **NCT ID:** NCT02661438
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-12
- **Primary completion:** 2016-03-17
- **Final completion:** 2016-03-17
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661438, "Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02661438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*